Switching to biosimilar bDMARDs is safe and efficacious Presented ByProf. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway TrialPhase 4, NOR-SWITCH ConferenceEULAR 2018 24 August, 2018 22:46